Vaccines currently being developed for Covid-19 should not be affected by recent mutations in the virus, according to a new study involving a University of York virologist.
The Association for Molecular Pathology (AMP) has released the preliminary results of its August 2020 SARS-CoV-2 Testing Survey for clinical laboratories. Respondents are experiencing continued supply chain interruptions and significant staffing shortages, all while demand for molecular diagnostic testing continues to increase.
A King County, Washington, initiative to relocate people from homeless shelters to hotel rooms during the pandemic not only limited the spread of COVID-19, but also improved people's mental health and well-being, and allowed them to focus on long-term goals.
Gender, age, education level, and political affiliation predict where people turn for information about COVID-19—and what sources they use and trust is linked to differing beliefs about the pandemic, according to a new study by NYU School of Global Public Health researchers.
How do parents separate myth from fact when it comes to trick-or-treating during the COVID-19 pandemic? Physicians with Penn State Children’s Hospital explore the answers.
While the world waits eagerly for a safe and effective vaccine to prevent infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the COVID-19 pandemic, researchers also are focusing on better understanding how SARS-CoV-2 attacks the body in the search for other means of stopping its devastating impact. The key to one possibility — blocking a protein that enables the virus to turn the immune system against healthy cells — has been identified in a recent study by a team of Johns Hopkins Medicine researchers.
A large, international study of COVID-19 patients confirmed that cardiovascular disease, hypertension, diabetes, congestive heart failure, chronic kidney disease, stroke and cancer can increase a patient’s risk of dying from the virus.
The U.S. Food and Drug Administration has granted emergency use authorization for UCLA Health to launch a new method of COVID-19 detection using sequencing technology called SwabSeq. Capable of testing thousands of samples at once, the method returns accurate, individual results in 12 to 24 hours.
Most COVID-19 (coronavirus) patients in Southern California during the early months of the pandemic appear to have been infected by a variant of the SARS-CoV-2 virus introduced to the region from New York state via Europe, not directly from China, where the virus was first detected, according to a new study conducted at Cedars-Sinai.
There's considerable risk that humans transmit SARS-CoV-2, the virus that causes COVID-19, to wildlife, according to a perspective article published in Mammal Review.
A mathematician from Cardiff University has developed a new method for processing large volumes of COVID-19 tests which he believes could lead to significantly more tests being performed at once and results being returned much quicker.
At night in a Ugandan forest, a team of American and African scientists take oral swabs from insect-eating cyclops leaf-nosed bats. In a necropsy room near the Baltic Sea, researchers try to determine what killed a donkey, a Bennett’s tree-kangaroo and a capybara at a German zoo — all of them suffering from severe brain swelling. Neither team was aware of the other, yet they were both about to converge on a discovery that would forever link them — and help solve a long-enduring mystery.
Virtual conference will highlight Lean innovations that have helped healthcare organizations plan for, manage and mitigate many aspects of the COVID-19 pandemic